
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4163997
[patent_doc_number] => 06139862
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Pharmaceutical dipeptide compositions and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/057347
[patent_app_country] => US
[patent_app_date] => 1998-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3838
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/139/06139862.pdf
[firstpage_image] =>[orig_patent_app_number] => 057347
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/057347 | Pharmaceutical dipeptide compositions and methods of use thereof | Apr 7, 1998 | Issued |
Array
(
[id] => 1383629
[patent_doc_number] => 06551994
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-22
[patent_title] => 'Compounds and methods for inhibiting the interaction between -catenin and -catenin'
[patent_app_type] => B1
[patent_app_number] => 09/057363
[patent_app_country] => US
[patent_app_date] => 1998-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 19056
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/551/06551994.pdf
[firstpage_image] =>[orig_patent_app_number] => 09057363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/057363 | Compounds and methods for inhibiting the interaction between -catenin and -catenin | Apr 7, 1998 | Issued |
| 09/053872 | METHOD FOR INHIBITING THROMBOSIS IN A PATIENT WHOSE BLOOD IS SUBJECTED TO EXTRACORPOREAL CIRCULATION | Mar 31, 1998 | Abandoned |
Array
(
[id] => 4183974
[patent_doc_number] => 06150335
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Tic-containing opioid dipeptide derivatives useful as analgesics'
[patent_app_type] => 1
[patent_app_number] => 9/043881
[patent_app_country] => US
[patent_app_date] => 1998-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4550
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150335.pdf
[firstpage_image] =>[orig_patent_app_number] => 043881
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/043881 | Tic-containing opioid dipeptide derivatives useful as analgesics | Mar 31, 1998 | Issued |
Array
(
[id] => 3982997
[patent_doc_number] => 05958884
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Compositions and methods for treating erectile dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/047594
[patent_app_country] => US
[patent_app_date] => 1998-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5438
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958884.pdf
[firstpage_image] =>[orig_patent_app_number] => 047594
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/047594 | Compositions and methods for treating erectile dysfunction | Mar 24, 1998 | Issued |
Array
(
[id] => 4115115
[patent_doc_number] => 06046167
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Peptide YY analogs'
[patent_app_type] => 1
[patent_app_number] => 9/047986
[patent_app_country] => US
[patent_app_date] => 1998-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10043
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046167.pdf
[firstpage_image] =>[orig_patent_app_number] => 047986
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/047986 | Peptide YY analogs | Mar 24, 1998 | Issued |
Array
(
[id] => 3945547
[patent_doc_number] => 05977066
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Cyclosporin galenic forms'
[patent_app_type] => 1
[patent_app_number] => 9/047056
[patent_app_country] => US
[patent_app_date] => 1998-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14337
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977066.pdf
[firstpage_image] =>[orig_patent_app_number] => 047056
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/047056 | Cyclosporin galenic forms | Mar 23, 1998 | Issued |
Array
(
[id] => 3906572
[patent_doc_number] => 05898028
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Method for producing powder formulation comprising an insulin'
[patent_app_type] => 1
[patent_app_number] => 9/045316
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3320
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/898/05898028.pdf
[firstpage_image] =>[orig_patent_app_number] => 045316
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/045316 | Method for producing powder formulation comprising an insulin | Mar 19, 1998 | Issued |
Array
(
[id] => 4409456
[patent_doc_number] => 06310038
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Pulmonary insulin crystals'
[patent_app_type] => 1
[patent_app_number] => 9/045038
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3368
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310038.pdf
[firstpage_image] =>[orig_patent_app_number] => 045038
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/045038 | Pulmonary insulin crystals | Mar 19, 1998 | Issued |
Array
(
[id] => 4260455
[patent_doc_number] => 06258774
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Carrier for in vivo delivery of a therapeutic agent'
[patent_app_type] => 1
[patent_app_number] => 9/044411
[patent_app_country] => US
[patent_app_date] => 1998-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19064
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258774.pdf
[firstpage_image] =>[orig_patent_app_number] => 044411
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/044411 | Carrier for in vivo delivery of a therapeutic agent | Mar 18, 1998 | Issued |
Array
(
[id] => 4406655
[patent_doc_number] => 06232287
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Molecules that home to various selected organs or tissues'
[patent_app_type] => 1
[patent_app_number] => 9/042107
[patent_app_country] => US
[patent_app_date] => 1998-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 21727
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232287.pdf
[firstpage_image] =>[orig_patent_app_number] => 042107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/042107 | Molecules that home to various selected organs or tissues | Mar 12, 1998 | Issued |
Array
(
[id] => 1311485
[patent_doc_number] => 06613737
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Process for the purification of a new motility-promoting protein from buffalo serum: a slaughter house waste'
[patent_app_type] => B1
[patent_app_number] => 09/037409
[patent_app_country] => US
[patent_app_date] => 1998-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3247
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09037409
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/037409 | Process for the purification of a new motility-promoting protein from buffalo serum: a slaughter house waste | Mar 9, 1998 | Issued |
| 08/930811 | COATING FOR BIO-MATERIAL INSERTABLE INTO THE BLOODSTREAM OR TISSUE OF THE HUMAN BODY | Mar 3, 1998 | Abandoned |
Array
(
[id] => 4137821
[patent_doc_number] => 06030629
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Photoprotective cosmetic/dermatological compositions comprising synergistic admixture of sunscreen compounds'
[patent_app_type] => 1
[patent_app_number] => 9/028359
[patent_app_country] => US
[patent_app_date] => 1998-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4003
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/030/06030629.pdf
[firstpage_image] =>[orig_patent_app_number] => 028359
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/028359 | Photoprotective cosmetic/dermatological compositions comprising synergistic admixture of sunscreen compounds | Feb 23, 1998 | Issued |
Array
(
[id] => 4086064
[patent_doc_number] => 06025328
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Antitumor agents'
[patent_app_type] => 1
[patent_app_number] => 9/026633
[patent_app_country] => US
[patent_app_date] => 1998-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14056
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 514
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025328.pdf
[firstpage_image] =>[orig_patent_app_number] => 026633
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/026633 | Antitumor agents | Feb 19, 1998 | Issued |
Array
(
[id] => 4297814
[patent_doc_number] => 06184344
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Synthesis of proteins by native chemical ligation'
[patent_app_type] => 1
[patent_app_number] => 8/945997
[patent_app_country] => US
[patent_app_date] => 1998-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 8698
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184344.pdf
[firstpage_image] =>[orig_patent_app_number] => 945997
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945997 | Synthesis of proteins by native chemical ligation | Feb 11, 1998 | Issued |
Array
(
[id] => 3949134
[patent_doc_number] => 05998579
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Epimorphin antagonist and process for producing it'
[patent_app_type] => 1
[patent_app_number] => 8/981012
[patent_app_country] => US
[patent_app_date] => 1998-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8588
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998579.pdf
[firstpage_image] =>[orig_patent_app_number] => 981012
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/981012 | Epimorphin antagonist and process for producing it | Feb 10, 1998 | Issued |
Array
(
[id] => 4277076
[patent_doc_number] => 06281195
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Matrix-free osteogenic devices, implants and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/019339
[patent_app_country] => US
[patent_app_date] => 1998-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21374
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281195.pdf
[firstpage_image] =>[orig_patent_app_number] => 019339
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/019339 | Matrix-free osteogenic devices, implants and methods of use thereof | Feb 4, 1998 | Issued |
Array
(
[id] => 3907121
[patent_doc_number] => 05898067
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Crystallization of proteins'
[patent_app_type] => 1
[patent_app_number] => 9/017085
[patent_app_country] => US
[patent_app_date] => 1998-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3074
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/898/05898067.pdf
[firstpage_image] =>[orig_patent_app_number] => 017085
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/017085 | Crystallization of proteins | Feb 1, 1998 | Issued |
Array
(
[id] => 4216855
[patent_doc_number] => 06087327
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Compositions and methods for chemodenervation using neurotoxins'
[patent_app_type] => 1
[patent_app_number] => 9/016123
[patent_app_country] => US
[patent_app_date] => 1998-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 9345
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087327.pdf
[firstpage_image] =>[orig_patent_app_number] => 016123
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/016123 | Compositions and methods for chemodenervation using neurotoxins | Jan 29, 1998 | Issued |